Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Total 13F shares
-
43,607,566
-
Share change
-
+979,839
-
Total reported value
-
$1,861,796,908
-
Put/Call ratio
-
33%
-
Price per share
-
$42.86
-
Number of holders
-
119
-
Value change
-
+$49,174,094
-
Number of buys
-
68
-
Number of sells
-
61
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q1 2024
As of 31 Mar 2024,
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,607,566 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Driehaus Capital Management LLC, FEDERATED HERMES, INC., JANUS HENDERSON GROUP PLC, TCG Crossover Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, RA CAPITAL MANAGEMENT, L.P., and Alyeska Investment Group, L.P..
This page lists
119
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.